Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of VTRNA1-3 mRNA | CTD | PMID:30851411 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of VTRNA1-3 gene | CTD | PMID:27153756 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of VTRNA1-3 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of VTRNA1-3 mRNA | CTD | PMID:32234424 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of VTRNA1-3 mRNA | CTD | PMID:31715268 | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of VTRNA1-3 mRNA | CTD | PMID:31629900 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of VTRNA1-3 mRNA | CTD | PMID:30851411 | sotorasib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VTRNA1-3 mRNA | CTD | PMID:36139627 | trametinib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VTRNA1-3 mRNA | CTD | PMID:36139627 | |